Page last updated: 2024-10-18

histamine and Triple Negative Breast Neoplasms

histamine has been researched along with Triple Negative Breast Neoplasms in 2 studies

Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.

Research Excerpts

ExcerptRelevanceReference
"The aim of this work was to improve the knowledge of the role of histamine in breast cancer by assessing the therapeutic efficacy of histamine and histamine H4 receptor (H4R) ligands in a triple-negative breast cancer (TNBC) model developed in immunocompetent hosts."7.96Study of the antitumour effects and the modulation of immune response by histamine in breast cancer. ( Cremaschi, GA; Formoso, K; Herrero Ducloux, MV; Martinel Lamas, D; Massari, NA; Medina, VA; Nicoud, MB; Sterle, HA; Táquez Delgado, MA, 2020)
"The aim of this work was to improve the knowledge of the role of histamine in breast cancer by assessing the therapeutic efficacy of histamine and histamine H4 receptor (H4R) ligands in a triple-negative breast cancer (TNBC) model developed in immunocompetent hosts."3.96Study of the antitumour effects and the modulation of immune response by histamine in breast cancer. ( Cremaschi, GA; Formoso, K; Herrero Ducloux, MV; Martinel Lamas, D; Massari, NA; Medina, VA; Nicoud, MB; Sterle, HA; Táquez Delgado, MA, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Nicoud, MB2
Ospital, IA1
Táquez Delgado, MA2
Riedel, J1
Fuentes, P1
Bernabeu, E1
Rubinstein, MR1
Lauretta, P1
Martínez Vivot, R1
Aguilar, MLÁ1
Salgueiro, MJ1
Speisky, D1
Moretton, MA1
Chiappetta, DA1
Medina, VA2
Sterle, HA1
Massari, NA1
Formoso, K1
Herrero Ducloux, MV1
Martinel Lamas, D1
Cremaschi, GA1

Other Studies

2 other studies available for histamine and Triple Negative Breast Neoplasms

ArticleYear
Nanomicellar Formulations Loaded with Histamine and Paclitaxel as a New Strategy to Improve Chemotherapy for Breast Cancer.
    International journal of molecular sciences, 2023, Feb-10, Volume: 24, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Drug Carriers; Histamine; Humans; Mice

2023
Study of the antitumour effects and the modulation of immune response by histamine in breast cancer.
    British journal of cancer, 2020, Volume: 122, Issue:3

    Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Databases

2020